jm + research + drugs   2

The 2018 Nobel Prize is a reminder of the outrageous cost of curing cancer
The penny drops:
One final disturbing aspect of the cancer cost conundrum: Public money helped pay for many of the drugs that patients can’t afford to access.

In a recent analysis, published in the journal PNAS, researchers found that American tax dollars helped fund the basic research that went into every single one of the drugs approved by the Food and Drug Administration between 2010 and 2016 — including several cancer immunotherapies. All told, $100 billion in National Institutes of Health research grants helped advance the science behind those drugs.

So the Nobel Prize this week is a reminder of the great promise of these drugs — and the incredible, lifesaving science that led to their discoveries. But it should also be a moment to reflect on who is benefiting from them and who isn’t. How will the 1.7 million Americans who are diagnosed with cancer per year gain access if prices keep rising and we don’t address this cost conundrum soon?
cancer  immunotherapy  drugs  costs  money  pharma  science  medicine  research 
20 days ago by jm
Ebola: While Big Pharma Slept
We’ve had almost 40 years to develop, test and stockpile an Ebola vaccine. That has not happened because big pharma has been entirely focused on shareholder value and profits over safety and survival from a deadly virus. For the better part of Ebola’s 38 years ‒ big pharma has been asleep. The question ahead is what virus or superbug will wake them up?
pharma  ebola  ip  patents  health  drugs  africa  research 
october 2014 by jm

Copy this bookmark:



description:


tags: